PJT Partners reported record Q2 2025 financial results, with GAAP revenue of $406.9 million (up 13% year-over-year) and adjusted EPS of $1.54, beating analyst expectations. Strategic advisory services drove performance, offsetting declines in placement fees.

PJT Partners (PJT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

PJT Partners (PJT) possesses solid growth attributes, which could help it handily outperform the market.

Blue Owl Capital Corporation (OBDC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

PJT Partners (PJT) possesses solid growth attributes, which could help it handily outperform the market.

PJT Partners (PJT) delivered earnings and revenue surprises of 117.78% and 44.47%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Ratings for PJT Partners (NYSE:PJT) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 1 2 1 1 Last 30D 0 0 0 0 1 1M Ago 0 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 0 2 1 0 The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $94.6, a high estimate of $110.00, and a low estimate of $75.00. This current average represents a 5.16% decrease from the previous average price target of $99.75. Interpreting Analyst Ratings: A Closer Look In examining recent analyst actions, we gain insights into how financial experts perceive PJT Partners. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Brennan Hawken UBS Lowers Sell $75.00 $100.00 Devin Ryan JMP Securities Raises Market Outperform $110.00 $105.00 Brennan Hawken UBS Raises Neutral $100.00 $86.00 James Yaro Goldman Sachs Lowers Neutral $99.00 $108.00 Steven Chubak Wolfe Research Announces Underperform $89.00 - Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to PJT Partners. This information provides a snapshot of how analysts perceive the current state of the company. Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to ...Full story available on Benzinga.com

Throughout the last three months, 5 analysts have evaluated PJT Partners (NYSE:PJT), offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 2 1 0 Last 30D 0 1 0 0 0 1M Ago 0 0 2 0 0 2M Ago 1 0 0 1 0 3M Ago 0 0 0 0 0 Analysts have set 12-month price targets for PJT Partners, revealing an average target of $101.2, a high estimate of $110.00, and a low estimate of $89.00. This upward trend is evident, with the current average reflecting a 2.48% increase from the previous average price target of $98.75. Analyzing Analyst Ratings: A Detailed Breakdown The analysis of recent analyst actions sheds light on the perception of PJT Partners by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Devin Ryan JMP Securities Raises Market Outperform $110.00 $105.00 Brennan Hawken UBS Raises Neutral $100.00 $86.00 James Yaro Goldman Sachs Lowers Neutral $99.00 $108.00 Steven Chubak Wolfe Research Announces Underperform $89.00 - Richard Ramsden Goldman Sachs Raises Buy $108.00 $96.00 Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to PJT ...Full story available on Benzinga.com

PJT Partners (PJT) delivered earnings and revenue surprises of 26.32% and 17.34%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

PJT Partners (PJT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Columbia Financial (CLBK) delivered earnings and revenue surprises of 28.57% and 3.08%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

In the latest quarter, 4 analysts provided ratings for PJT Partners (NYSE:PJT), showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 2 1 0 Last 30D 0 0 2 0 0 1M Ago 1 0 0 1 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $99.0, a high estimate of $108.00, and a low estimate of $89.00. Observing a 2.41% increase, the current average has risen from the previous average price target of $96.67. Deciphering Analyst Ratings: An In-Depth Analysis The analysis of recent analyst actions sheds light on the perception of PJT Partners by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Brennan Hawken UBS Raises Neutral $100.00 $86.00 James Yaro Goldman Sachs Lowers Neutral $99.00 $108.00 Steven Chubak Wolfe Research Announces Underperform $89.00 - Richard Ramsden Goldman Sachs Raises Buy $108.00 $96.00 Key Insights: Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to PJT Partners. This information provides a snapshot of how analysts perceive the current ...Full story available on Benzinga.com